All News

PSS.scleroderma.arthritis.contractures

Best of 2024: BSR Guidelines for Systemic Sclerosis Management

Jack Cush, MD

The British Society for Rheumatology has updated its 2015 guidelines for the management of patients with systemic sclerosis (SSc) based on published evidence, systematic literature review and expert opinion.

Read Article
RheumNow Podcast square

Bah Humbug Vitamin D (12.20.2024)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article
Seo RNL

Best of 2024: Vasculitis Pearls

Richard Conway, MBBChBAO, PhD

Once again RheumNow Live 2024 really delivered with high impact learning packed into short sessions. As someone with an interest in vasculitis it was fantastic to see four of my favorite speakers in the Vasculitis Mavens and STEP talks. They gave us what we really want from these talks – personal opinions and approaches that go beyond the guidelines. They really dropped a selection of pearls on us and I wanted to share a few of these with you.

Read Article
price%20dollar%20pill.jpg

Abuse of the Safety-Net 340B Drug Programs

Jack Cush, MD

Dr. Madelaine Feldman has written an important commentary on the 340B Drug Pricing Program, a safety-net program that would allow vulnerable populations to receive expensive new therapies. But she points out that "this well-intentioned program has strayed from its original purpose", allowing certain hospitals and for-profit pharmacies to exploit the program.

Read Article
What is Osteoarthritis? A downloadable patient education page from JAMA. https://t.co/PfoimFgxRp https://t.co/WVQbofTzGC

Links:

Dr. John Cush RheumNow ( View Tweet)
Myths by Daniel Clauw Small fiber neuropathy - misnomer, non-specific, not worth getting a skin biopsy Fibromyalgia is not autoimmune - it is nociplastic pain and treated differently #ACR24 Review Course @RheumNow https://t.co/7SGKMTC3HY https://t.co/0718sGsass

Links:

Dr. John Cush RheumNow ( View Tweet)
Improvements in Pain and Fatigue in Bimekizumab Dr. Philip Mease discusses abstract 2368, presented at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/ON09z9yTuJ https://t.co/650TUdHwYm

Links:

Dr. John Cush RheumNow ( View Tweet)
Vaccine Responses:The DMARD Counts Dr. David Liew reviews abstracts 0247, 0248, 1988, 1009, reporting from Melbourne, Australia for the 2024 ACR Convergence meeting. https://t.co/0qDGRkT64B https://t.co/dO9EvhD1NE

Links:

Dr. John Cush RheumNow ( View Tweet)
#ACR24 Year in Review: 💡GLP1i significantly decreased knee OA pain over time (or was it the wt loss itself?🤨) 💡CD19 CAR T-Cell therapy has potential to treat/cure many autoimmune diseases (are risks and $ worth the benefit?) 💡 High risk of CV events within 30 days of gout… https://t.co/g3egOpCYNr https://t.co/KMiOEP7pSg
Dr. John Cush RheumNow ( View Tweet)
Sarcoidosis is biopsy supported not proven” -Dx is clinical with broad ddx. -Assess organ involvement in all pts. -Whole body PET can help assess disease activity (not in CNS disease) -MR brain with pituitary cuts helpful in CNS sarcoid. #ACR24 @ACRheum @RheumNow… https://t.co/Ka1cHtFOqj

Dr. John Cush RheumNow ( View Tweet)

RheumNow Live 2025: Feb 8-9, Dallas, TX! 🔬 Don’t miss top experts on Psoriatic Disease: ➡️ A. Ogdie: Preventing PsA ➡️ A. Kavanaugh: Biologic Therapies ➡️ K. Gordon: Head-to-Head Studies Register now! https://t.co/9qnqtpkwpT https://t.co/95TGS56vyA

Links:

Dr. John Cush RheumNow ( View Tweet)
Best of 2024: Analgesic Prescribing in Patients with Inflammatory Arthritis https://t.co/iQrBVzWaI8 https://t.co/Rx86Q57oEZ

Links:

Dr. John Cush RheumNow ( View Tweet)
Bah Humbug Vitamin D (12.20.2024) https://t.co/Mjuk6buRsX https://t.co/aX8cetkbWc

Links:

Dr. John Cush RheumNow ( View Tweet)
A Fibroblast Renaissance Dr. Andrea Fava at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/GQXWkqMkIW https://t.co/W6UXT4HCeg

Links:

Dr. John Cush RheumNow ( View Tweet)
Palliative Care in Rheumatology Dr. Jiha Lee talks with Dr. Shannon Herndon about abstracts 0204 and 1064, presented at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/fqx8wGLTqI https://t.co/5mwJx3ZN6u

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live 2025: Feb 8-9, Dallas, TX! 🔬 Don’t miss top experts on Psoriatic Disease: ➡️ A. Ogdie: Preventing PsA ➡️ A. Kavanaugh: Biologic Therapies ➡️ K. Gordon: Head-to-Head Studies Register now! https://t.co/BTLmc8HSKY https://t.co/KVsLF3yOZx

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Are Emulation Trials a Fantasy? https://t.co/eCO8a1UFlB https://t.co/PPczmxYFKa

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us at RheumNow Live February 8 & 9 in Dallas, TX! Our incredible meeting will feature speakers like: Rheumatology Power Trio: Exploring RA Management in Older Adults, AI Innovations, and Multimorbidity Strategies Una Makris, MD, MSc Jeff Curtis, MD, MS, MPH Bryant… https://t.co/570WrI6RHT https://t.co/TTGtcNmWx7
Dr. John Cush RheumNow ( View Tweet)
2024 Match results are in - Rheumatology- 287 matched, 99%: Top 6: 1. Cardi 99.8% 2. Cardio EP 98% 3. Endocrinology 98.4 % 4. GI 99.6% 5. Heme/Onc 99.7% 6. Rheum 99% https://t.co/UYnXc13VvQ https://t.co/kAZ4GACXkL

Links:

Dr. John Cush RheumNow ( View Tweet)
Predicting Flares in Rheumatoid Arthritis Dr. Jonathan Kay interviews Dr. John Isaacs about abstract 1349, presented at the 2024 ACR Convergence meeting in Washington, DC. https://t.co/pM1AgPiRla https://t.co/0hP5y1JgPq

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×